Work

Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade

Year: 2026

Type: article

Source: Cell

DOI: 10.1016/j.cell.2026.03.041

Authors: Mykhaylo Usyk, Richard B. Hayes, Rob Knight, Antonio Gonzalez, Huilin Li, Iman Osman, Jeffrey S. Weber, Jiyoung Ahn

Institutions: Albert Einstein College of Medicine, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, University of California San Diego

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, University of California, San Diego, National Cancer Institute, National Institute of Environmental Health Sciences, U.S. National Library of Medicine, Division of Cancer Epidemiology and Genetics, National Cancer Institute

Awards: NYU Cancer Health Disparity (CHD) SPORE, G1476237564, G164956139, G3091915247, Illumina NovaSeq 6000 Sequencing System, The Oral Mycobiome and Risk of Pancreatic Cancer, The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer, NYU Melanoma SPORE, G6611862716, G7444027728, Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk, G8945900622, Maintenance and Enhancement of the Asian American enriched Cohort, Asian American Community Cohort of the New York Metropolitan Area, Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study, Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome, Cancer Center Support Grant

OpenAlex ID: W7154728940

FWCI: 10.37

Cites: 42

Cited by: 7

Related to: 10